Literature DB >> 1702805

Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis.

Y Okano1, T A Medsger.   

Abstract

We found serum autoantibodies directed against the proteins binding exclusively to U4/U6 of Sm small nuclear ribonucleoprotein particle (snRNP) in serum from a patient (MaS) with systemic sclerosis. Their specificity, called anti-MaS, is distinct from that of known antibodies against U snRNP. The U4 and U6 small nuclear RNA from a 32P-labeled HeLa cell extract and five proteins with Mr 150,000, 120,000, 80,000, 36,000, and 34,000, in addition to Sm core proteins (B, B', D, E, F, and G) from an [35S] methionine-labeled extract, were immunoprecipitated by anti-MaS in isotonic solution. However, the Sm core proteins and U4 and U6 small nuclear RNA were separated from the protein-A-Sepharose facilitated MaS immunoprecipitate by incubation in a solution containing 500 mM NaCl. In immunoblots, anti-MaS antibodies reacted with one protein of Mr 150,000 from a HeLa cell nuclear extract that was fractionated by SDS-PAGE and transferred to a nitrocellulose sheet. The monospecific immunoaffinity purified antibody eluted from the immunoblot band immunoprecipitated U4 and U6 small nuclear RNA and reblotted the protein with Mr 150,000. These data indicate that anti-MaS antibodies recognize at least one antigenic protein that binds exclusively to the U4/U6 snRNP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702805

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

Authors:  Noreen Fertig; Robyn T Domsic; Tatiana Rodriguez-Reyna; Masataka Kuwana; Mary Lucas; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Rheum       Date:  2009-07-15

2.  Rare scleroderma autoantibodies to the U11 small nuclear ribonucleoprotein and to the trimethylguanosine cap of U small nuclear RNAs.

Authors:  A C Gilliam; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Reconstituted mammalian U4/U6 snRNP complements splicing: a mutational analysis.

Authors:  T Wolff; A Bindereif
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

4.  Roles of U4 and U6 snRNAs in the assembly of splicing complexes.

Authors:  P Vankan; C McGuigan; I W Mattaj
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

5.  A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction.

Authors:  O Gozani; J G Patton; R Reed
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

6.  Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death.

Authors:  P J Utz; M Hottelet; W J van Venrooij; P Anderson
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

7.  Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.

Authors:  Océane Landon-Cardinal; Alexandra Baril-Dionne; Sabrina Hoa; Alain Meyer; Valérie Leclair; Josiane Bourré-Tessier; Anne-Marie Mansour; Farah Zarka; Jean-Paul Makhzoum; Jessica Nehme; Eric Rich; Jean-Richard Goulet; Tamara Grodzicky; Martial Koenig; France Joyal; Isabelle Richard; Marie Hudson; Ira Targoff; Minoru Satoh; Marvin J Fritzler; Yves Troyanov; Jean-Luc Senécal
Journal:  RMD Open       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.